As EGFR is overexpressed in approximately 90% of HNSCC tumors [10]–[12], we examined the effect of GSPs on the levels of EGFR and its down-stream target ERK1/2 in HNSCC cells. Here, MAPK3 is linked to head and neck squamous cell carcinoma.